Company: SMNR
Filing Date: 2025-04-21
Form Type: S-4/A
Source: 0001193125-25-087342
Chunk: 580

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-21
Form: S-4/A
Chunk 580
---
             |     |      |      |     |            |         |     |          |   |     |            |   |     |                  |        |    |     |           |         |
| Henry Ji, Ph.D.                     |     |      | 2024 |     |            |  17,308 |     |          | — |     |            | — |     |                  |    996 | -1 |     |           |  18,304 |
| Treasurer and Secretary             |     |      |      |     |            |         |     |          |   |     |            |   |     |                  |        |    |     |           |         |
| Stephen Ma                          |     |      | 2024 |     |            | 128,308 |     |          | — |     |            | — |     |                  |  8,884 | -1 |     |           | 137,192 |
| Anticipated Chief Financial Officer |     |      |      |     |            |         |     |          |   |     |            |   |     |                  |        |    |     |           |         |

| (1) | Represents (i) matching contributions made under the Company’s 401(k) plan, (ii) health insurance premiums paid by Semnur and (iii) life insurance premiums paid by Semnur. |

Narrative Disclosure to Summary Compensation Table During the year ended December 31, 2024, Semnur had only two named executive officers that provided services to Semnur: Jaisim Shah, Semnur’s Chief Executive Officer and Henry Ji, Ph.D., Semnur’s Treasurer and Secretary. Scilex’s Chief Financial Officer, Stephen Ma, also provided services to Semnur during such time but is not currently an executive officer of Semnur. However as Semnur anticipates that Mr. Ma will serve as Semnur’s Chief Financial Officer following the closing of the Business Combination, Semnur is including Mr. Ma in its Summary Compensation Table below.

358

As Semnur is a wholly owned subsidiary of Scilex and executives of Scilex are required to provide services to Scilex’s subsidiaries, neither Dr. Ji nor Mr. Shah nor Mr. Ma has received any additional cash or equity compensation from Semnur for services rendered to Semnur for the year ended December 31, 2024 and Semnur